DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Browsing by Subject
Showing results 3039 to 3058 of 7641
< previous
next >
- systemic lupus erythematosus, hepatorrhia, autolysis ("liver death"), early diagnosis, criteria 1
- systemic lupus erythematosus, HIV-infection, differential diagnosis. 1
- systemic lupus erythematosus, kidney disease, tumor necrosis factor α, C-reactive protein 1
- Systemic Lupus Erythematosus; Atherosclerosis, Nontraditional Cardiovascular Risk Factors; Treatment 1
- systemic scleroderma, 25(OH)vitamin D3, calcium, osteoporosis, osteopenia, bone mineral density, densitometry 2
- Systemic Scleroderma, Atherosclerosis, Cardiovascular Risk Factors 1
- Systemic scleroderma, cardiovascular system, il-6, treatment, statins, tocilizumab. 1
- systemic scleroderma, fibrosis, treatment, ACE inhibitors 1
- systemic scleroderma, peripheral vascular damage, pulse therapy, remission. 1
- systemic scleroderma; sclerodermic renal crisis; vascular endothelial dysfunction; chronic sclerodermic nephropathy; nonimmune factors of nephropathy progression; chronic kidney disease. 1
- Systemic sclerosis, anti-nuclear antibodies, fibrillarin-(U3-RNP), AFA- anti-fibrillarin antibodies, Raynaud's phenomenon 1
- Systemic sclerosis, anti-nuclear antibodies, fibrillarin-(U3-RNP), AFA- anti-fibrillarin antibodies, Raynaud’s phenomenon. 1
- systemic sclerosis, intestinal tract, large intestine obstruction 1
- Systemic sclerosis; atherosclerosis; heart disease; fibrosis; endothelial dysfunction. 1
- systemic vasculitis, covid-19 infection, nodular erythema,necrotic vasculitis,polyangiitic granulematosis, immunocomplex 1
- systemicvasculitis, Wegener's granulematosis 1
- systolic hypertension, antihypertensive monotherapy, lercanidipine 1
- Ta'sirlangan ichak sindromi, рsixoemotsional buzilishlar, ratsional-emotiv psixoterapiya, psixofarmakoterapiya, Gamilton shkalasi 1
- Tadqiqot maqsadi bolalarda fankoni nefronofti- zining klinik – etiologik xususiyatlarini o‘ganish. 1
- Tadqiqotga 19– 50 (35,6±10,3) yoshdagi, Bo‘g‘imlar funktsional holatining buzilishlarini 1